V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006438 | 200011718 | 1.71 | 68.7 | Palliative (P) | null | 2019-06-13 | null | null | N | PERM TRIAL | 100161771 |
| 200006440 | 200011720 | 1.83 | 75.6 | Palliative (P) | 2020-05-04 | 2020-05-08 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101770149 |
| 200006441 | 200011721 | 1.75 | 86.45 | null | 2018-08-12 | 2018-09-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100070604 |
| 200006443 | 200011723 | 1.59 | 70.3 | null | 2021-03-29 | 2021-04-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101777147 |
| 200006446 | 200011726 | 1.7 | 89.6 | Palliative (P) | 2017-01-07 | 2017-01-16 | DABRAFENIB | 02 | null | DABRAFENIB | 100651671 |
| 200006447 | 200011727 | null | null | null | null | 2017-09-19 | null | null | null | BINIMETINIB + ENCORAFENIB | 101310528 |
| 200006448 | 200011728 | null | null | null | 2016-12-31 | 2016-12-31 | null | N | null | DABRAFENIB | 101219397 |
| 200006449 | 200011729 | 1.77 | 115.3 | Palliative (P) | 2019-05-11 | 2019-05-22 | CEMIPLIMAB | 02 | N | DABRAFENIB | 100752666 |
| 200006450 | 200011730 | 1.66 | 53 | null | 2016-11-09 | 2016-11-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100159130 |
| 200006452 | 200011732 | 1.76 | 120 | Palliative (P) | 2017-01-18 | 2017-03-02 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100620057 |
| 200006453 | 200011733 | 1.73 | 82.9 | Palliative (P) | 2017-12-06 | 2018-03-28 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100699383 |
| 200006454 | 200011734 | null | 90.4 | null | 2019-11-07 | 2020-06-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100545598 |
| 200006455 | 200011735 | 1.84 | 92.6 | 03 | 2019-09-06 | 2019-09-22 | Ipilimumab | N | null | IPILIMUMAB + NIVOLUMAB | 100855564 |
| 200006456 | 200011736 | 1.78 | 106 | 03 | 2018-01-01 | 2018-01-22 | DABRAFENIB | 02 | null | DABRAFENIB | 101531999 |
| 200006457 | 200011737 | 1.64 | 100.4 | Palliative (P) | 2016-04-19 | 2016-04-19 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101212679 |
| 200006458 | 200011738 | 1.8 | 89 | Palliative (P) | 2021-03-13 | 2021-04-04 | Trial Unspecified | 02 | null | IPILIMUMAB + NIVOLUMAB | 101374505 |
| 200006460 | 200011740 | 1.72 | 78 | Palliative (P) | null | 2016-07-01 | Ipilimumab | 01 | null | TRIAL UNSPECIFIED | 101387696 |
| 200006465 | 200011745 | 1.7 | 82.6 | Palliative (P) | null | 2017-10-24 | null | null | null | TRIAL | 100763139 |
| 200006468 | 200011748 | 1.64 | 58.9 | Palliative (P) | 2019-08-16 | 2019-08-27 | DABRAFENIB | 02 | null | DABRAFENIB | 101776673 |
| 200006470 | 200011750 | 1.65 | 76.2 | Palliative (P) | null | 2020-11-05 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100381565 |
| 200006471 | 200011751 | 1.76 | 55.4 | Palliative (P) | 2021-05-05 | 2021-05-12 | INTERIM Trial | 02 | null | DABRAFENIB | 100813628 |
| 200006472 | 200011752 | 1.8 | 68.8 | Palliative (P) | null | 2020-02-13 | Ipilimumab | null | null | IPILIMUMAB | 101669951 |
| 200006473 | 200011753 | 1.61 | 56.4 | Curative (C) | 2020-03-25 | 2020-07-29 | DABRAFENIB | 02 | null | DABRAFENIB | 100834328 |
| 200006474 | 200011754 | 0 | 0 | Curative (C) | 2019-02-10 | 2019-02-10 | Ipilimumab | 02 | null | IPILIMUMAB | 100330263 |
| 200006476 | 200011755 | null | 120 | Palliative (P) | 2019-05-23 | 2021-02-23 | DABRAFENIB | 02 | N | DABRAFENIB | 101552161 |
| 200006477 | 200011756 | 1.84 | 92 | Palliative (P) | 2020-03-06 | 2020-03-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101631635 |
| 200006478 | 200011757 | null | 104 | Palliative (P) | 2014-12-02 | 2016-07-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100814353 |
| 200006480 | 200011759 | null | 80 | Palliative (P) | 2019-08-13 | 2019-08-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100695170 |
| 200006482 | 200011761 | 1.58 | 49 | Palliative (P) | 2018-01-12 | 2018-02-06 | DABRAFENIB | 02 | null | DABRAFENIB | 101497330 |
| 200006483 | 200011762 | 1.65 | 92 | Palliative (P) | null | 2017-02-10 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100249583 |
| 200006486 | 200011765 | 1.83 | 108.2 | Palliative (P) | 2017-04-16 | 2017-04-21 | Ipilimumab | 02 | null | TRIAL UNSPECIFIED | 101541767 |
| 200006487 | 200011766 | 1.8 | 87.1 | Palliative (P) | 2017-11-14 | 2018-09-15 | Ipilimumab | 02 | N | IPILIMUMAB + NIVOLUMAB | 101371683 |
| 200006489 | 200011768 | null | 60.2 | null | 2019-01-09 | 2019-01-24 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100008150 |
| 200006490 | 200011769 | 1.85 | 103 | Palliative (P) | 2019-09-08 | 2019-09-13 | DABRAFENIB | 02 | null | DABRAFENIB | 101102963 |
| 200006491 | 200011770 | null | 51.5 | Adjuvant (A) | 2017-06-18 | 2017-06-27 | Dacarbazine | 02 | null | BLEOMYCIN | 100120109 |
| 200006492 | 200011771 | 1.56 | 90 | null | 2017-12-23 | 2018-01-05 | Binimetinib + Encorafenib | N | null | DABRAFENIB | 100322713 |
| 200006494 | 200011773 | 1.59 | 81 | Palliative (P) | 2018-12-25 | 2019-01-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101590525 |
| 200006495 | 200011774 | 1.6 | 73.5 | Palliative (P) | 2018-04-27 | 2018-05-08 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100946542 |
| 200006496 | 200011775 | null | 75 | Palliative (P) | 2018-03-23 | 2018-03-23 | null | 01 | null | TRIAL | 101802371 |
| 200006497 | 200011776 | 2 | 83.4 | Palliative (P) | 2016-11-19 | 2017-03-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100538394 |
| 200006499 | 200011778 | 1.68 | 98 | Adjuvant (A) | 2016-10-08 | 2018-01-20 | DABRAFENIB | 02 | null | DABRAFENIB | 100485505 |
| 200006500 | 200011779 | null | 67 | Palliative (P) | 2021-05-28 | 2021-05-28 | Ipilimumab | null | null | IPILIMUMAB | 101252769 |
| 200006503 | 200011782 | null | 68.2 | Palliative (P) | 2019-05-07 | 2019-05-08 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100484362 |
| 200006505 | 200011784 | null | 87.6 | Palliative (P) | 2017-10-01 | 2017-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101735727 |
| 200006506 | 200011785 | 1.83 | 70.9 | Palliative (P) | 2019-12-28 | 2020-01-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101812261 |
| 200006507 | 200011786 | 0 | 0 | Palliative (P) | 2019-06-26 | 2019-06-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101031070 |
| 200006508 | 200011787 | 1.76 | 86.7 | Palliative (P) | 2018-12-01 | 2018-12-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101218751 |
| 200006511 | 200011790 | 1.72 | 78 | Palliative (P) | 2016-01-03 | 2016-04-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100323449 |
| 200006512 | 200011791 | null | null | null | null | 2019-03-31 | null | null | null | TALIMOGENE LAHERPAREPVEC | 101396018 |
| 200006514 | 200011793 | 1.59 | 61.95 | null | 2016-09-15 | 2016-09-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101460095 |